Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905148-25-000413
Filing Date
2025-02-06
Accepted
2025-02-06 20:27:22
Documents
1
Period of Report
2025-02-04

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 4603
  Complete submission text file 0000905148-25-000413.txt   6008
Mailing Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-624-1100
RIGEL PHARMACEUTICALS INC (Issuer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 301 PENOBSCOT DRIVE REDWOOD CITY CA 94063
Business Address
Schorno Dean L (Reporting) CIK: 0001509688 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29889 | Film No.: 25598920